As of 2024-12-12, the Relative Valuation of Medifast Inc (MED) is 63.29 USD. This relative valuation is based on P/E multiples. With the latest stock price at 20.98 USD, the upside of Medifast Inc based on Relative Valuation is 201.7%.
The range of the Relative Valuation is 15.88 - 140.14 USD.
| Range | Selected | |
| Trailing P/E multiples | 23.7x - 30.9x | 29.4x |
| Forward P/E multiples | 18.7x - 27.7x | 21.1x |
| Fair Price | 15.88 - 140.14 | 63.29 |
| Upside | -24.3% - 568.0% | 201.7% |
| Date | P/E |
| 2024-12-10 | 32.49 |
| 2024-12-09 | 31.34 |
| 2024-12-06 | 29.96 |
| 2024-12-05 | 29.81 |
| 2024-12-04 | 29.48 |
| 2024-12-03 | 28.70 |
| 2024-12-02 | 29.63 |
| 2024-11-29 | 29.37 |
| 2024-11-27 | 29.03 |
| 2024-11-26 | 27.36 |
| 2024-11-25 | 27.81 |
| 2024-11-22 | 27.49 |
| 2024-11-21 | 27.33 |
| 2024-11-20 | 27.12 |
| 2024-11-19 | 25.86 |
| 2024-11-18 | 26.24 |
| 2024-11-15 | 27.09 |
| 2024-11-14 | 27.30 |
| 2024-11-13 | 29.22 |
| 2024-11-12 | 28.99 |
| 2024-11-11 | 29.02 |
| 2024-11-08 | 28.61 |
| 2024-11-07 | 29.69 |
| 2024-11-06 | 29.42 |
| 2024-11-05 | 30.46 |
| 2024-11-04 | 28.09 |
| 2024-11-01 | 27.75 |
| 2024-10-31 | 27.45 |
| 2024-10-30 | 27.91 |
| 2024-10-29 | 27.64 |
| 2024-10-28 | 26.64 |
| 2024-10-25 | 26.01 |
| 2024-10-24 | 26.34 |
| 2024-10-23 | 26.25 |
| 2024-10-22 | 25.82 |
| 2024-10-21 | 26.52 |
| 2024-10-18 | 27.04 |
| 2024-10-17 | 26.73 |
| 2024-10-16 | 26.85 |
| 2024-10-15 | 26.58 |
| 2024-10-14 | 25.91 |
| 2024-10-11 | 26.91 |
| 2024-10-10 | 26.88 |
| 2024-10-09 | 26.57 |
| 2024-10-08 | 27.57 |
| 2024-10-07 | 27.73 |
| 2024-10-04 | 27.54 |
| 2024-10-03 | 27.30 |
| 2024-10-02 | 27.40 |
| 2024-10-01 | 28.70 |